FOS and breast cancer: Here, we present NR4A1 as a key determinant that modulates BC growth by competing with c-Fos to regulate the transcription of PRDX6 and restrain lipid remodeling and redox balance disruption through comprehensive genomic, transcriptomic and metabolomic analyses.